Deco, Gustavo https://orcid.org/0000-0002-8995-7583
Sanz Perl, Yonatan
Johnson, Samuel https://orcid.org/0000-0002-8648-1735
Bourke, Niamh
Carhart-Harris, Robin L.
Kringelbach, Morten L. https://orcid.org/0000-0002-3908-6898
Article History
Received: 22 November 2023
Accepted: 12 July 2024
First Online: 5 August 2024
Competing interests
: R.L.C.-H. reports receiving consulting fees from COMPASS Pathways, Entheon Biomedical, Mydecine, Synthesis Institute, Tryp Therapeutics and Usona Institute. The other authors declare no competing interests.